Latest HCA news and sentiment

Kiltearn Partners LLP Acquires Shares of 37,314 HCA Healthcare, Inc. $HCA

Kiltearn Partners LLP has acquired a new position of 37,314 shares in HCA Healthcare, valued at approximately $14.5 million, making it the fund's 9th largest holding. Institutional investors now own 62.73% of HCA. Despite several analysts lowering their price targets, the company maintains a "Moderate Buy" consensus rating with an average target of $462.64, having recently reported strong quarterly earnings and declared a $0.78 per share dividend.

Kendall Capital Management Invests $1.40 Million in HCA Healthcare, Inc. $HCA

Kendall Capital Management has acquired a new position in HCA Healthcare, Inc. worth approximately $1.40 million. Institutional investors hold 62.73% of the company, and analysts generally rate the stock a "Moderate Buy" with an average target price of $462.64. HCA Healthcare recently reported strong quarterly revenues and earnings, exceeding expectations, and declared a quarterly dividend.

Elevation Point Wealth Partners LLC Acquires New Position in HCA Healthcare, Inc. $HCA

Evolve Private Wealth LLC Invests $3.21 Million in HCA Healthcare, Inc. $HCA

Evolve Private Wealth LLC has acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, purchasing 8,224 shares valued at approximately $3.21 million. This investment comes as several other institutional investors also adjusted their positions in the healthcare company. HCA Healthcare recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend.

10,563 Shares in HCA Healthcare, Inc. $HCA Bought by B. Metzler seel. Sohn & Co. AG

B. Metzler seel. Sohn & Co. AG acquired 10,563 shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, valued at approximately $4.1 million, contributing to institutional investors owning 62.73% of the company. HCA Healthcare reported strong quarterly earnings of $7.59 per share, exceeding estimates, and declared a quarterly dividend of $0.78 per share. Despite several analysts lowering price targets, the company maintains a consensus "Moderate Buy" rating with an average price target of $462.64.

Harber Asset Management LLC Invests $5.04 Million in HCA Healthcare, Inc. $HCA

Harber Asset Management LLC initiated a new position in HCA Healthcare, Inc. by purchasing 12,930 shares valued at $5.04 million, making it 3% of the firm's portfolio. HCA Healthcare exceeded quarterly earnings expectations with $7.59 EPS and $20.23 billion in revenue, also declaring a quarterly dividend of $0.78. Analysts maintain a "Moderate Buy" consensus with an average price target of $462.64 for the company.

Advisors Capital Management LLC Buys Shares of 6,507 HCA Healthcare, Inc. $HCA

HCA Healthcare Jumps 6.0% After JP Morgan Maintains Neutral

HCA Healthcare shares surged 6.0% to $430.79 on Friday, despite JP Morgan cutting its price target from $490 to $425 and maintaining a Neutral rating. The unexpected rally suggests investors may be looking beyond the analyst's more conservative outlook, possibly anticipating stronger operational performance or improved industry fundamentals. This divergence highlights the complexity of market sentiment around HCA, a major hospital operator, as trading volume reached 750,059 shares.

5,422 Shares in HCA Healthcare, Inc. $HCA Bought by Silvant Capital Management LLC

Silvant Capital Management LLC acquired 5,422 shares of HCA Healthcare, Inc. valued at approximately $2.1 million during the second quarter. Institutional investors hold a significant 62.73% stake in the company. Despite recent price target reductions, HCA Healthcare maintains a consensus "Moderate Buy" rating from analysts, driven by strong quarterly earnings and revenue growth.

Paralel Advisors LLC Purchases Shares of 4,883 HCA Healthcare, Inc. $HCA

Paralel Advisors LLC has acquired 4,883 shares of HCA Healthcare, Inc., valued at approximately $1.9 million, bringing the total institutional ownership to 62.73%. Despite some analyst price target reductions, the stock holds a "Moderate Buy" consensus rating with a target of $462.64, significantly above its recent trading price. HCA Healthcare also reported strong quarterly earnings, beating expectations with $7.59 adjusted EPS and $20.23 billion in revenue, and declared a quarterly dividend of $0.78 per share.

18,176 Shares in HCA Healthcare, Inc. $HCA Purchased by Wealthfront Advisers LLC

Wealthfront Advisers LLC recently acquired 18,176 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $7.09 million during the second quarter. Other institutional investors have also adjusted their holdings in HCA, which currently has a "Moderate Buy" rating from analysts with an average price target of $465.59. The company recently reported strong quarterly earnings, beating consensus estimates, and declared a quarterly dividend of $0.78 per share.

Csenge Advisory Group Invests $1.03 Million in HCA Healthcare, Inc. $HCA

Csenge Advisory Group recently invested $1.03 million in HCA Healthcare, acquiring 2,638 shares. This comes as institutional investors collectively own 62.73% of the company, with major funds like BlackRock Inc. and State Street Corp increasing their stakes. Despite some recent target price reductions, analysts maintain a "Moderate Buy" consensus rating for HCA Healthcare, which also reported strong quarterly earnings and declared a quarterly dividend.

2,710 Shares in HCA Healthcare, Inc. $HCA Acquired by Perigon Wealth Management LLC

Perigon Wealth Management LLC acquired 2,710 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $1.06 million during the second quarter. The article details other institutional investments, analyst ratings, and the company's financial performance, including exceeding quarterly expectations and declaring a $0.78 per share dividend. HCA Healthcare maintains a "Moderate Buy" consensus rating among analysts.

Meeder Advisory Services Inc. Acquires Shares of 5,936 HCA Healthcare, Inc. $HCA

Meeder Advisory Services Inc. has purchased a new stake of 5,936 shares in HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $2.314 million during the second quarter. Other institutional investors have also adjusted their positions in HCA Healthcare. The company recently announced a quarterly dividend of $0.78 per share, with an ex-dividend date of September 16th.

Mitsubishi UFJ Asset Management Co. Ltd. Invests $147.94 Million in HCA Healthcare, Inc. $HCA

Mitsubishi UFJ Asset Management Co. Ltd. recently acquired a new stake in HCA Healthcare, purchasing 379,450 shares valued at approximately $147.94 million in the second quarter, representing 0.18% of the company's stock. Other institutional investors have also adjusted their holdings in HCA Healthcare, which currently has a "Moderate Buy" rating from analysts with an average target price of $465.59. The company also announced a quarterly dividend of $0.78 per share, payable on September 30th.

Foster & Motley Inc. Takes $11.03 Million Position in HCA Healthcare, Inc. $HCA

Foster & Motley Inc. has acquired a new stake of 28,296 shares in HCA Healthcare, Inc. (NYSE:HCA), valued at approximately $11.03 million during the second quarter. Other institutional investors have also adjusted their holdings in HCA, which recently reported strong quarterly earnings, beating analyst expectations with $7.59 EPS and $20.23 billion in revenue. The company also announced a quarterly dividend of $0.78 per share, and analysts currently have a "Moderate Buy" consensus rating with an average price target of $465.59.

13,003,600 Shares in HCA Healthcare, Inc. $HCA Acquired by BlackRock Inc.

BlackRock Inc. has acquired a significant new stake in HCA Healthcare, purchasing 13,003,600 shares valued at approximately $5.07 billion, representing about 6.01% of the company. Other hedge funds have also adjusted their positions, and HCA Healthcare recently announced earnings that beat analyst estimates and a quarterly dividend of $0.78 per share. Analysts generally rate HCA Healthcare as a "Moderate Buy" with an average price target of $465.59.

Danske Bank A S Takes $116.86 Million Position in HCA Healthcare, Inc. $HCA

Danske Bank A S has acquired a new position in HCA Healthcare, Inc. (NYSE:HCA), purchasing 299,722 shares valued at approximately $116.86 million, representing 0.14% of the company. HCA Healthcare reported strong quarterly earnings, surpassing analyst expectations with $7.59 EPS and $20.23 billion in revenue, and has an average "Moderate Buy" rating from analysts with an average price target of $465.59. The company also declared a quarterly dividend of $0.78 per share, yielding 0.8%.